Pharmaceutical Research

, Volume 13, Issue 8, pp 1252–1257

Oxidation of Human Insulin-like Growth Factor I in Formulation Studies: Kinetics of Methionine Oxidation in Aqueous Solution and in Solid State

  • Jonas Fransson
  • Ebba FIorin-Robertsson
  • Kent Axelsson
  • Christina Nyhlén

DOI: 10.1023/A:1016032808039

Cite this article as:
Fransson, J., FIorin-Robertsson, E., Axelsson, K. et al. Pharm Res (1996) 13: 1252. doi:10.1023/A:1016032808039


Purpose. The aim of this work was to study the kinetics of oxidation of methionine in human Insulin-like Growth Factor I (hIGF-I)1 in aqueous solution and in the solid state by the aid of quantification of oxygen.

Methods. The oxidized form of hIGF-I was characterized by tryptic peptide analysis, RP-HPLC and FAB-MS and quantified by RP-HPLC. The oxygen content was quantified polarographically by a Clark-type electrode.

Results. Second-order kinetics with respect to amount of protein and dissolved oxygen was found to be appropriate for the oxidation of methionine in hIGF-I. The rate constants ranged from 1 to 280 M−1 month−l and had an activation energy of 95 (+/−4) kJ/mole. Light exposure, storage temperature and oxygen content were found to have a considerable impact on the oxidation rates. No significant difference in reaction rates was found for the oxidation of hIGF-I in aqueous solution or in the solid state. A method for decreasing the oxygen content in aqueous solution without purging is described.

Conclusions. Polarographic quantification of dissolved oxygen makes it possible to establish the kinetics for oxidation of proteins. The oxidation of methionine in hIGF-I appears to follow second-order kinetics.

hIGF-I oxidation methionine HPLC kinetics 

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Jonas Fransson
    • 1
    • 2
  • Ebba FIorin-Robertsson
    • 1
  • Kent Axelsson
    • 3
  • Christina Nyhlén
    • 4
  1. 1.Department of Pharmaceutical TechnologyPharmacia, BiopharmaceuticalsSweden
  2. 2.Department of Pharmaceutics, Faculty of PharmacyUppsala UniversitySweden
  3. 3.Department of BiochemistryPharmacia, BiopharmaceuticalsSweden
  4. 4.Department of Process DevelopmentPharmacia, BiopharmaceuticalsSweden
  5. 5.Department of Pharmaceutical TechnologyPharmacia, BiopharmaceuticalsSweden; e-mail

Personalised recommendations